Clinical pharmacology of dilevalol (III). A pharmacokinetic study of dilevalol in elderly subjects with essential hypertension.

Abstract

Dilevalol (100 mg) was given once daily for 8 days in eight elderly subjects with essential hypertension. Blood samples for plasma dilevalol concentrations were taken during an 8-hour post-drug period following the first and eighth dosages, and the time to maximum concentration (tmax), maximum plasma concentration (Cmax), distribution half-life (t1/2 alpha… (More)

Topics

Cite this paper

@article{Fujimura1989ClinicalPO, title={Clinical pharmacology of dilevalol (III). A pharmacokinetic study of dilevalol in elderly subjects with essential hypertension.}, author={Akio Fujimura and Koh-ichi Sugimoto and Yuji Kumagai and Hiroaki Nakashima and Aya Ebihara}, journal={Journal of clinical pharmacology}, year={1989}, volume={29 11}, pages={1008-12} }